KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Change in Cash (2016 - 2025)

Idexx Laboratories has reported Change in Cash over the past 17 years, most recently at -$28.1 million for Q4 2025.

  • Quarterly results put Change in Cash at -$28.1 million for Q4 2025, down 37.93% from a year ago — trailing twelve months through Dec 2025 was -$108.2 million (up 34.69% YoY), and the annual figure for FY2025 was -$108.2 million, up 34.69%.
  • Change in Cash for Q4 2025 was -$28.1 million at Idexx Laboratories, down from $43.6 million in the prior quarter.
  • Over the last five years, Change in Cash for IDXX hit a ceiling of $198.9 million in Q3 2023 and a floor of -$124.3 million in Q1 2025.
  • Median Change in Cash over the past 5 years was -$8.2 million (2022), compared with a mean of -$10.2 million.
  • Biggest five-year swings in Change in Cash: surged 1885.05% in 2022 and later crashed 4692.11% in 2024.
  • Idexx Laboratories' Change in Cash stood at -$749000.0 in 2021, then surged by 1885.05% to $13.4 million in 2022, then soared by 814.26% to $122.2 million in 2023, then plummeted by 116.66% to -$20.4 million in 2024, then crashed by 37.93% to -$28.1 million in 2025.
  • The last three reported values for Change in Cash were -$28.1 million (Q4 2025), $43.6 million (Q3 2025), and $624000.0 (Q2 2025) per Business Quant data.